We only have this paper's title and publication details.
Read it at the sourceRandomized crossover trial evaluates albuminuria reduction with dapagliflozin and eplerenone in chronic kidney disease, suggesting therapeutic potential for combination therapy.
European Union Clinical Trials Register, EU 2017-004641-25.
No takes yet. Share an insight, caveat, or question.
Provenzano et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: